The Company granted 0.4 and 2.3 restricted stock units, respectively, during the three and six months ended June 30, 2026 with weighted average grant date fair values of $15.45 and $10.54 per share. The Company granted — and 0.9 performance stock units, respectively, during the three and six months ended June 30, 2026 with weighted average grant date fair values of $— and $11.66 per share.

Total stock-based compensation expense and the associated income tax benefits recognized by the Company in the condensed consolidated statements of operations were as follows:


	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Direct costs	$	8.2	$	17.2	$	16.3	$	28.8
Selling, general and administrative expenses	4.4		5.5		7.7		8.5
Total stock compensation expense	$	12.6	$	22.7	$	24.0	$	37.3

Income tax benefits	$	2.0	$	3.1	$	3.9	$	5.4